IGF2BP3 and urinary bladder cancer: GSEA analysis indicated a positive correlation between IGF2BP3 levels and “INFLAMMATORY RESPONSE” and “ALLOGRAFT REJECTION” in bladder cancer datasets (Fig. 7A–C).